These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 3133400)

  • 1. Artificial factor VIII deficient plasma: preparation using monoclonal antibodies and its use in one stage coagulation assays.
    Hornsey VS; Waterston YG; Prowse CV
    J Clin Pathol; 1988 May; 41(5):562-7. PubMed ID: 3133400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combined use of monoclonal antibody-based enzyme-linked immunosorbent assays (ELISA) for factor VIII antigen (VIII:Ag) and von Willebrand factor antigen (vWF:Ag) for the detection of carriers of haemophilia A.
    Furlong RA; Chesham J; Peake IR
    Clin Lab Haematol; 1988; 10(3):295-305. PubMed ID: 3141105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease.
    Böhm M; Täschner S; Kretzschmar E; Gerlach R; Favaloro EJ; Scharrer I
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):39-45. PubMed ID: 16607078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of factor VIII deficient plasma by immunodepletion using three monoclonal antibodies.
    Takase T; Rotblat F; Goodall AH; Kernoff PB; Middleton S; Chand S; Denson KW; Austen DE; Tuddenham EG
    Br J Haematol; 1987 Aug; 66(4):497-502. PubMed ID: 3117089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardisation of factor VIII and von Willebrand factor in plasma: calibration of the 4th International Standard (97/586).
    Hubbard AR; Rigsby P; Barrowcliffe TW
    Thromb Haemost; 2001 Apr; 85(4):634-8. PubMed ID: 11341497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Properties of factor VIII/von Willebrand factor in two highly-purified factor VIII concentrates, Hemofil M and Monoclate, using monoclonal antibodies].
    Tanaka I; Yoshioka A; Shima M; Fujiwara T; Terada S; Nakai H; Miyata S; Sawamoto Y; Kamisue S; Fukui H
    Rinsho Ketsueki; 1989 Jul; 30(7):951-7. PubMed ID: 2509762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time.
    Aihara M; Kimura A; Chiba Y; Yoshida Y
    Thromb Haemost; 1988 Jun; 59(3):485-90. PubMed ID: 3142084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between factor VIII:Ag and factor VIII in recombinant and plasma-derived factor VIII concentrates.
    Lin Y; Yang X; Chevrier MC; Craven S; Barrowcliffe TW; Lemieux R; Ofosu FA
    Haemophilia; 2004 Sep; 10(5):459-69. PubMed ID: 15357771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of factor-VIII-depleted plasma with antibodies and its use for the assay of factor VIII.
    Rothschild C; Amiral J; Adam M; Meyer D
    Haemostasis; 1990; 20(6):321-8. PubMed ID: 2129163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The type of factor VIII deficient plasma used influences the performance of the Nijmegen modification of the Bethesda assay for factor VIII inhibitors.
    Verbruggen B; Giles A; Samis J; Verbeek K; Mensink E; Novákovà I
    Thromb Haemost; 2001 Dec; 86(6):1435-9. PubMed ID: 11776311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimers of von Willebrand antigen in therapeutic factor VIII concentrates.
    Vukovich TC
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(6):831-40. PubMed ID: 2436998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.
    Chediak J; Peake I; Bloom A
    Thromb Haemost; 1983 Aug; 50(2):509-12. PubMed ID: 6415844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An improvemed assay for von Willebrand factor.
    Head DR; Bowman RP; Marmer DJ; Brossoit AD
    Am J Clin Pathol; 1979 Dec; 72(6):991-5. PubMed ID: 117698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.
    Lippi G; Franchini M; Salvagno GL; Montagnana M; Poli G; Guidi GC
    J Thromb Thrombolysis; 2008 Oct; 26(2):150-3. PubMed ID: 17786534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sensitive ELISA for von Willebrand factor (vWf:Ag).
    Ingerslev J
    Scand J Clin Lab Invest; 1987 Apr; 47(2):143-9. PubMed ID: 3107116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies against the human factor VIII von Willebrand molecule: characterization and potential for screening of von Willebrand patients.
    Avner P; Arnaud D; Sultan Y; Maisonneuve P; Jeanneau C
    Dev Biol Stand; 1984; 57():69-76. PubMed ID: 6084622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential supplementary utility of combined PFA-100 and functional von Willebrand factor testing for the laboratory assessment of desmopressin and factor concentrate therapy in von Willebrand disease.
    Favaloro EJ; Thom J; Patterson D; Just S; Baccala M; Dixon T; Meiring M; Koutts J; Rowell J; Baker R
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):475-83. PubMed ID: 19584715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease.
    Escolar G; Carretero M; Magallón M; Quintana M; Arnau C; Castillo R; Aznar-Salatti J
    Haematologica; 1998 Nov; 83(11):1009-14. PubMed ID: 9864923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor VIII related activities in concentrates.
    Nilsson IM; Borge L; Gunnarsson M; Kristoffersson AC
    Scand J Haematol Suppl; 1984; 41():157-72. PubMed ID: 6440282
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.